Alnylam Pharmaceuticals
ALNY
ALNY
329 hedge funds and large institutions have $11.8B invested in Alnylam Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 121 increasing their positions, 96 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.98% more ownership
Funds ownership: 94.95% → 95.93% (+0.98%)
4% less capital invested
Capital invested by funds: $12.3B → $11.8B (-$444M)
33% less funds holding in top 10
Funds holding in top 10: 12 → 8 (-4)
Holders
329
Holding in Top 10
8
Calls
$154M
Puts
$134M
Top Buyers
| 1 | +$115M | |
| 2 | +$102M | |
| 3 | +$58.7M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$38.5M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$31.2M |
Top Sellers
| 1 | -$218M | |
| 2 | -$100M | |
| 3 | -$17.5M | |
| 4 |
Dodge & Cox
San Francisco,
California
|
-$17.2M |
| 5 |
Morgan Stanley
New York
|
-$16.9M |